健細胞科技股份有限公司
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
The core product of 健細胞科技股份有限公司 is the "Cancell" digital medical platform, which provides three major services:
1. Smart Butler Service: Integrates the ePRO (electronic Patient-Reported Outcomes) system, allowing cancer patients to record 15 common side effect symptoms. The system automatically analyzes the data and provides personalized improvement suggestions, enabling physicians to monitor patient conditions in real-time for early intervention.
2. Dr.Cell AI Intelligent Medical Assistant: Utilizes a self-developed cancer integrative medicine LLM (Large Language Model) to provide 24-hour AI consultation services. Every answer is authored by professional physicians, and it features a "one-click ask" function for easy use by patients.
3. Remote Physician Consultation Room: Establishes a one-on-one private chat room between doctors and patients, allowing physicians to proactively provide personalized treatment recommendations.
The platform also offers additional features such as health promotion tasks, C-Coin point redemption for health foods, and mutual support communities for cancer patients.
1. Smart Butler Service: Integrates the ePRO (electronic Patient-Reported Outcomes) system, allowing cancer patients to record 15 common side effect symptoms. The system automatically analyzes the data and provides personalized improvement suggestions, enabling physicians to monitor patient conditions in real-time for early intervention.
2. Dr.Cell AI Intelligent Medical Assistant: Utilizes a self-developed cancer integrative medicine LLM (Large Language Model) to provide 24-hour AI consultation services. Every answer is authored by professional physicians, and it features a "one-click ask" function for easy use by patients.
3. Remote Physician Consultation Room: Establishes a one-on-one private chat room between doctors and patients, allowing physicians to proactively provide personalized treatment recommendations.
The platform also offers additional features such as health promotion tasks, C-Coin point redemption for health foods, and mutual support communities for cancer patients.
The content above was translated by Ai
Founded Year
2021
Unified Business No.
90836950
Status
Active
Number of Employees
0
Total Paid-in
Capital
2,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
健細胞科技股份有限公司 is an innovative technology company focusing on digital cancer healthcare. Combining software development technology with medical expertise, the company is dedicated to creating innovative AI medical software and services. The company's flagship product, "Cancell醫抗癌", is Taiwan's first cancer care SaaS telemedicine platform. First launched at the end of 2020, it is patient-centered and addresses the pain point of cancer patients' lack of care after discharge through AI-driven digital therapeutics.
The content above was translated by Ai
